This article was reviewed by Dipika V. Patel, MRCOphth, PhD
This article was reviewed by Steve Charles, MD
Patient adherence to treatment can sometimes be tricky—especially when out-of-pocket costs are considered.
When it comes to diabetic eye diseases, there are a multitude of potential treatments—but perhaps the “easiest” one for patients is to ensure their A1C levels are under control.1
One of the most common questions I am asked by other surgeons is how to talk to patients about premium IOLs. It is so important to do this in an efficient but open, honest, and patient-centric way.
This article was reviewed by Uday Devgan, MD
This article was reviewed by Prof Gus Gazzard, FRCOpthMA, MBBCHIR, MD
Novel therapeutic approaches and drug-delivery technologies are improving control of pain and inflammation after cataract and other ocular surgeries.
This article was reviewed by Konstantin Petrukhin, PhD
This article was reviewed by Dr. Charles C. Wykoff, MD, PhD